Anatara Lifesciences (ANR.ASX)
Biotechnology: Gastrointestinal health
About Anatara
Anatara Lifesciences Ltd (ASX: ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need.
Anatara is focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is a commitment to delivering real outcomes for patients and strong value for our shareholders.
Candour and Anatara
Candour has been engaged as Anatara's corproate and investor relations advisor since mid 2022. We have assisted management and aligned shareholders throughout a period of restructuring, focusing the Company on its lead gastrointestinal program.
Additionally, Candour is actively assessing new potential biotechnology assets that are aligned with Anatara's corporate mission and have the potential to deliver strong shareholder returns.
Candour Commentary
1 / Item Title
Describe the item and include any relevant details. Click to edit the text.
1 / Item Title
Describe the item and include any relevant details. Click to edit the text.
1 / Item Title
Describe the item and include any relevant details. Click to edit the text.
2 / Item Title
Describe the item and include any relevant details. Click to edit the text.
3 / Item Title
Describe the item and include any relevant details. Click to edit the text.